Substance Use and Survival after Treatment for Chronic Myelogenous Leukemia (CML) or Myelodysplastic Syndrome (MDS)

REFERENCES

• Passik SD, Portenoy RK, Ricketts PL. Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis. Oncology (Williston Park) 1998; 12:517–521.
   PubMed Web of Science ®Google Scholar
• Stagno SJ, Busby K, Shapiro A, Kotz MM. Patients at risk: Addressing addiction in patients undergoing hematopoetic SCT. Bone Marrow Transplant 2008; 42: 221–226.
   PubMedGoogle Scholar
• Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, Christakis N. A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ 2003; 327:195–201.
   PubMed Web of Science ®Google Scholar
• Hoodin F, Uberti JP, Lynch TJ, Steele P, Ratanatharathorn V. Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant 2006; 38:255–264.
   PubMed Web of Science ®Google Scholar
• Polednak AP. Documentation of alcohol use in hospital records of newly diagnosed cancer patients: A population based study. Am J Drug Alcohol Abuse 2007; 33:403–409.
   PubMed Web of Science ®Google Scholar
• Quintas-Cardama A, Cortes JE. Chronic myeloid leukemia: Diagnosis and treatment. Mayo Clin Proc 2006; 81:973–988.
   PubMed Web of Science ®Google Scholar
• Steensma DP, Bennett JM. The myelodysplastic syndromes: Diagnosis and treatment. Mayo Clin Proc 2006; 81:104–130.
   PubMed Web of Science ®Google Scholar
• Chang G, Meadows, M-E, Orav EJ, Antin JH. Mental status changes after hematopoietic stem cell transplantation. Cancer. Published online: 23 June 2009. DOI: 10.1002/cncr.24496. 2009; 115:4625–4635.
   PubMedGoogle Scholar
• Hasin DS, Stinson FS, Ogburn E, Grant, BF. Prevalence, correlates, disability, and comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States. Arch Gen Psych 2007; 64:830–842.
   PubMed Web of Science ®Google Scholar
• Compton WM, Thonas YF, Stinson FW, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States. Arch Gen Psych 2007; 64:566–576.
   Google Scholar
• Carey MS, Bacon M, Tu D, Butler L, Bezjak A, Stuart GC. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecol Oncol 2008; 108:100–105.
   PubMed Web of Science ®Google Scholar
• Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: A systemic, quantitative review. Cancer 2001; 91:2214–2221.
   PubMed Web of Science ®Google Scholar
• Hart CL, Taylor MD, Davey-Smith G, Whalley LJ, Starr JM, Hole DJ, Wilson V, Deary IJ. Childhood IQ, social class, deprivation and their relationships with mortality and morbidity risk in later life: Prospective observational study linking the Scottish mental survey 1932 and midspan studies. Psychosom Med 2003; 65:877–883.
   PubMed Web of Science ®Google Scholar
• Crook ED, Peters M. Health disparities in chronic diseases: Where the money is. Am J Med Sci 2008; 335:266–270.
   PubMedGoogle Scholar
• Nakao K, Treas J. Computing 1989 prestige scores. GSS Methological Report No. 70. Chicago, IL: NORC, 1990.
   Google Scholar
• Zachary RA. Shipley Institute of Living Scale. Revised Manual. Los Angeles, CA: Western Psychological Services, 1991.
   Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for axis I DSM-IV disorders. Patient edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute, 1994.
   Google Scholar
• McHorney CA, Ware JE, Raczek AE. The MOS 36-Item, short-form health survey (SF-36): Psychometric and clinical uses of validity in measuring physical and mental constructs. Med Care 1993; 331:247–263.
   Google Scholar
• Cella DF, Jacobsen PB, Orav EJ, Holland JC, Silberfarb PM, Rafla S. A brief POMS measure of distress for cancer patients. J Chronic Dis 1987; 40:939–942.
   PubMedGoogle Scholar
• Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life in cancer patients: The functional living index—Cancer: Development and validation. J Clin Oncol 1984; 2:472–483.
   PubMed Web of Science ®Google Scholar
• Chapter 7.2.5: Hollingshead's Index of Social Position. In: Miller DC, Salkind NJ ( eds). Handbook of Research Design and Social Measurement, 6th Edition; Thousand Oaks, CA: Sage Publications, 2002; pp. 463–469.
   Google Scholar
• Chen K, Scheier LM, Kandel DB. Effects of chronic cocaine use on physical health: A prospective study in a general population sample. Drug Alcohol 1996; 43:23–37.
   PubMed Web of Science ®Google Scholar
• Rosenkranz HS, Klopman G. The carcinogenic potential of cocaine. Cancer Lett 1990; 52:243–243.
   PubMedGoogle Scholar
• Garnder B, Zhu LX, Roth MD, Tashkin DP, Dubinette SM, Sharma S. Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol 2004; 147:95–98.
   PubMedGoogle Scholar
• Aurora T, Gunnerson K, Urrunaga J, Baltarowich L, Muzzin A, Rivers E. Prevalence study of cocaine use in the elderly. Acad Emerg Med 2000; 7(5):499.
   Google Scholar
• Chang G, Orav EJ, McNamara TK, Tong MY, Antin JH. Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome. Cancer 2004; 101:782–789.
   PubMedGoogle Scholar
• Hoodin F, Kallbfleish KR, Thornton J, Ratanatharathorn V. Psychosocial influences on 305 adults’ survival after bone marrow transplantation; depression, smoking, and behavioral self-regulation. J Psychosom Res 2004; 57:145–154.
   PubMedGoogle Scholar
• Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol 2006; 24:5132–5137.
   PubMed Web of Science ®Google Scholar
• Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: A review. Ann Oncol 2006; 17:5–19.
   PubMed Web of Science ®Google Scholar